Literature DB >> 17256070

Cryopreservation of human embryonic stem cells: a protocol by programmed cooling.

Peng-Fei Yang1, Tse-Chao Hua, Jing Wu, Zhao-Hua Chang, Hsiao-Chien Tsung, Yi-Lin Cao.   

Abstract

Human embryonic stem (ES) cells have far-reaching applications in the areas of tissue engineering, regenerative medicine, pharmacology and basic scientific research. Although the culture conditions can maintain the human ES cells in an undifferentiated state for a transient period, spontaneous differentiation has also been observed during the routine culturing of ES cells. However, the maintenance of ES cells in the undifferentiated, pluripotent state for extended periods of time will be required in many areas of scientific research. Cryopreservation is a technology with potentially far reaching implication for the development and widespread use of such cell lines. This study was undertaken to develop and optimize a protocol for cryopreservation of human ES cells through programmed cooling. The effects of the seeding temperature, the cooling rate and the sub-zero temperature to which the samples were cooled before plunging into liquid nitrogen(the terminal temperature), all significantly affected the recovery of cryopreserved ES cells. After studying these factors, an improved protocol was obtained: the sample was cooled from 0 degree C to -35 degree C at a cooling rate of 0.5 degree per min, with seeding was set at -10 degree C, before being plunged immediately into the liquid nitrogen. Using this protocol, 9 of 11 colony fragments survived freezing and thawing and could be cultured for prolonged periods. They retained the properties of pluripotent cells, had a normal karyotype and showed histochemical staining for alkaline phosphatase.

Entities:  

Mesh:

Year:  2006        PMID: 17256070

Source DB:  PubMed          Journal:  Cryo Letters        ISSN: 0143-2044            Impact factor:   1.066


  8 in total

1.  Cryopreservation of Human Stem Cells for Clinical Application: A Review.

Authors:  Charles J Hunt
Journal:  Transfus Med Hemother       Date:  2011-03-16       Impact factor: 3.747

2.  An effective serum- and xeno-free chemically defined freezing procedure for human embryonic and induced pluripotent stem cells.

Authors:  Frida Holm; Susanne Ström; José Inzunza; Duncan Baker; Anne-Marie Strömberg; Björn Rozell; Anis Feki; Rosita Bergström; Outi Hovatta
Journal:  Hum Reprod       Date:  2010-03-05       Impact factor: 6.918

3.  Protein kinase A inhibitor, H89, significantly enhances survival rate of dissociated human embryonic stem cells following cryopreservation.

Authors:  Liang Zhang; Yanqing Xu; Jiandong Xu; Yuping Wei; Xia Xu
Journal:  Cell Prolif       Date:  2016-08-03       Impact factor: 6.831

4.  ROCK inhibition enhances the recovery and growth of cryopreserved human embryonic stem cells and human induced pluripotent stem cells.

Authors:  David A Claassen; Michelle M Desler; Angie Rizzino
Journal:  Mol Reprod Dev       Date:  2009-08       Impact factor: 2.609

Review 5.  Human embryonic stem cells: derivation, maintenance and cryopreservation.

Authors:  Jeoung Eun Lee; Dong Ryul Lee
Journal:  Int J Stem Cells       Date:  2011-06       Impact factor: 2.500

6.  Freezing Responses in DMSO-Based Cryopreservation of Human iPS Cells: Aggregates Versus Single Cells.

Authors:  Rui Li; Guanglin Yu; Samira M Azarin; Allison Hubel
Journal:  Tissue Eng Part C Methods       Date:  2018-03-28       Impact factor: 3.056

7.  Bioprocessing of cryopreservation for large-scale banking of human pluripotent stem cells.

Authors:  Yan Li; Teng Ma
Journal:  Biores Open Access       Date:  2012-10

8.  Insights into Species Preservation: Cryobanking of Rabbit Somatic and Pluripotent Stem Cells.

Authors:  Lucie Gavin-Plagne; Florence Perold; Pierre Osteil; Sophie Voisin; Synara Cristina Moreira; Quitterie Combourieu; Véronique Saïdou; Magali Mure; Gérard Louis; Anne Baudot; Samuel Buff; Thierry Joly; Marielle Afanassieff
Journal:  Int J Mol Sci       Date:  2020-10-02       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.